News LUMIBIRD

Equities

Market Closed - Euronext Paris Other stock markets 11:35:04 2024-06-10 am EDT			5-day change	1st Jan Change
12 ^EUR	-4.38%		-6.61%	-1.48%

May. 23	Lumibird: strategic plan confirms objectives	CF
May. 03	Lumibird launches product for dry eyes	CF

Lumibird: strategic plan confirms objectives	May. 23	CF
LUMIBIRD PRESENTS ITS NEW STRATEGIC PLAN	May. 22	GL
Lumibird launches product for dry eyes	May. 03	CF
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE	May. 03	GL
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE	May. 03	AQ
Lumibird: over 7% growth in quarterly sales	Apr. 23	CF
LUMIBIRD: PUBLICATION OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT INCLUDING THE ANNUAL FINANCIAL REPORT	Apr. 05	GL
LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2024	Mar. 25	GL
Lumibird: EBITDA improved by 10% in 2023	Mar. 13	CF
LUMIBIRD: ANNUAL RESULTS 2023	Mar. 12	GL
Lumibird SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
LUMIBIRD : nombre d'actions au 29 février 2024	Mar. 07	PU
Lumibird: two orders from Saab for OdiPro	Mar. 01	CF
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR CV90	Feb. 29	GL
Lumibird: the stock outperforms after a positive note	Feb. 19	CF
Lumibird: sales up by almost 7% in 2023	Jan. 30	CF
LUMIBIRD: 2023 REVENUES AT €203.6M	Jan. 29	GL
The LUMIBIRD Group Reports Unaudited Consolidated Sales Results for the Fourth Quarter and Full Year Ended 31 December 2023	Jan. 29	CI
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA	Jan. 26	GL
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA	Jan. 26	AQ

No results for this search